RE:RE:RE:RE:LABS is also a "clinical stage" pharma company. "over 20 Sorry not reviewing 2022 transcripts for you. I know he said it..maybe this can help.
3 Results
Of the 400 matches from the literature search, only 10% (43) of the publications reported data from trials or clinical protocols regarding medical Cannabis. The relevant trials were carried out in: Australia, Brazil, Canada, Denmark, Germany, Israel, Netherlands, Switzerland, the United Kingdom, and the United States of America. Given their geographical distribution, these countries can be considered of interest despite the small number of studies available.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174563/